GIS
AMGN icon

Grayhawk Investment Strategies’s Amgen AMGN Stock Holding History

Grayhawk Investment Strategies’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,578
Closed -$454K – 172
2023
Q4 		$454K Buy
+1,578
New +$430K 0.23% 86

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Grayhawk Investment Strategies's AMGN Position: Q1 2024 in Review

Grayhawk Investment Strategies sold out of Amgen (AMGN) in Q1 2024, closing a stake of 1,578 shares — an estimated $454K sold.

Grayhawk Investment Strategies first reported a position in AMGN in Q4 2023 and held it in 1 quarter. The position peaked at $454K in Q4 2023. 2,716 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Grayhawk Investment Strategies reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Grayhawk Investment Strategies sold 1,578 Amgen shares in Q1 2024, an estimated $454K.
  • Grayhawk Investment Strategies first reported a position in Amgen in Q4 2023 and held it in 1 quarter.
  • Grayhawk Investment Strategies's Amgen position peaked at $454K in Q4 2023.
  • 2,716 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Grayhawk Investment Strategies's 13F filing for Q1 2024, filed 15 May 2024.